Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2009
Total Assets: $212.95B
Liabilities Breakdown FY2009
Total Liabilities: $122.50B
Asset Breakdown
Total Assets: $212.95B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.98B | 0.9% |
| Accounts Receivable | $14.65B | 6.9% |
| Inventory | $12.40B | 5.8% |
| Property, Plant & Equipment | $22.78B | 10.7% |
| Goodwill | $42.36B | 19.9% |
| Intangible Assets | $68.02B | 31.9% |
| Other Assets | $50.77B | 23.8% |
Liabilities Breakdown
Total Liabilities: $122.50B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.37B | 3.6% |
| Long-Term Debt | $43.19B | 35.3% |
| Other Liabilities | $74.94B | 61.2% |